Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model

Experimental Cell Research

Volumn 318, Issue 10, 2012, Pages 1160-1174

  Farini, Andrea ^a   Sitzia, Clementina ^a   Navarro, Claire ^b   D'Antona, Giuseppe ^c   Belicchi, Marzia ^a   Parolini, Daniele ^a   Del Fraro, Giulia ^a   Razini, Paola ^a   Bottinelli, Roberto ^c   Meregalli, Mirella ^a   Torrente, Yvan ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSERM   (France)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Dysferlin; Lymphocytes; Scid A J mice

Indexed keywords

CREATINE KINASE; DYSFERLIN; DYSTROPHIN; LAMININ; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 2A; UNCLASSIFIED DRUG;

ABDOMINAL WALL MUSCULATURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIAPHRAGM; DYSFERLINOPATHY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY INFILTRATE; MACROPHAGE; MOUSE; MUSCLE FORCE; MUSCLE REGENERATION; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84860368512     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.03.010     Document Type: Article

References (47)

1. Bashir A., Liu Y.T., Raphael B.J., Carson D., Bafna V. Optimization of primer design for the detection of variable genomic lesions in cancer. Bioinformatics 2007, 23:2807-2815.
2. Anderson L.V., Davison K., Moss J.A., Young C., Cullen M.J., Walsh J., Johnson M.A., Bashir R., Britton S., Keers S., Argov Z., Mahjneh I., Fougerousse F., Beckmann J.S., Bushby K.M. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet. 1999, 8:855-861.
3. Achanzar W.E., Ward S. A nematode gene required for sperm vesicle fusion. J. Cell Sci. 1997, 110(Pt 9):1073-1081.
4. Confalonieri P., Oliva L., Andreetta F., Lorenzoni R., Dassi P., Mariani E., Morandi L., Mora M., Cornelio F., Mantegazza R. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J. Neuroimmunol. 2003, 142:130-136.
5. Selcen D., Stilling G., Engel A.G. The earliest pathologic alterations in dysferlinopathy. Neurology 2001, 56:1472-1481.
6. Gallardo E., Rojas-Garcia R., de Luna N., Pou A., Brown R.H., Illa I. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 2001, 57:2136-2138.
7. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., Aikawa E., Mempel T.R., Libby P., Weissleder R., Pittet M.J. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
8. Han R., Campbell K.P. Dysferlin and muscle membrane repair. Curr. Opin. Cell Biol. 2007, 19:409-416.
9. Ho M., Post C.M., Donahue L.R., Lidov H.G., Bronson R.T., Goolsby H., Watkins S.C., Cox G.A., Brown R.H. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum. Mol. Genet. 2004, 13:1999-2010.
10. Bittner R.E., Anderson L.V., Burkhardt E., Bashir R., Vafiadaki E., Ivanova S., Raffelsberger T., Maerk I., Hoger H., Jung M., Karbasiyan M., Storch M., Lassmann H., Moss J.A., Davison K., Harrison R., Bushby K.M., Reis A. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat. Genet. 1999, 23:141-142.
11. Vafiadaki E., Reis A., Keers S., Harrison R., Anderson L.V., Raffelsberger T., Ivanova S., Hoger H., Bittner R.E., Bushby K., Bashir R. Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation. Neuroreport 2001, 12:625-629.
12. Bernard C.C., Carnegie P.R. Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J. Immunol. 1975, 114:1537-1540.
13. Rosenberg N.L., Ringel S.P., Kotzin B.L. Experimental autoimmune myositis in SJL/J mice. Clin. Exp. Immunol. 1987, 68:117-129.
14. Vainzof M., Ayub-Guerrieri D., Onofre P.C., Martins P.C., Lopes V.F., Zilberztajn D., Maia L.S., Sell K., Yamamoto L.U. Animal models for genetic neuromuscular diseases. J. Mol. Neurosci. 2008, 34:241-248.
15. Bansal D., Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., McNeil P.L., Campbell K.P. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172.
16. Charge S.B., Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84:209-238.
17. Chazaud B., Sonnet C., Lafuste P., Bassez G., Rimaniol A.C., Poron F., Authier F.J., Dreyfus P.A., Gherardi R.K. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell Biol. 2003, 163:1133-1143.
18. Arnold L., Henry A., Poron F., Baba-Amer Y., van Rooijen N., Plonquet A., Gherardi R.K., Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 2007, 204:1057-1069.
19. Summan M., Warren G.L., Mercer R.R., Chapman R., Hulderman T., Van Rooijen N., Simeonova P.P. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1488-R1495.
20. Teixeira C.F., Zamuner S.R., Zuliani J.P., Fernandes C.M., Cruz-Hofling M.A., Fernandes I., Chaves F., Gutierrez J.M. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve 2003, 28:449-459.
21. Han R., Frett E.M., Levy J.R., Rader E.P., Lueck J.D., Bansal D., Moore S.A., Ng R., Beltran-Valero de Bernabe D., Faulkner J.A., Campbell K.P. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J. Clin. Invest. 2010, 120:4366-4374.
22. Nagaraju K., Rawat R., Veszelovszky E., Thapliyal R., Kesari A., Sparks S., Raben N., Plotz P., Hoffman E.P. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. Am. J. Pathol. 2008, 172:774-785.
23. Rawat R., Cohen T.V., Ampong B., Francia D., Henriques-Pons A., Hoffman E.P., Nagaraju K. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am. J. Pathol. 2010, 176:2891-2900.
24. Villalta S.A., Nguyen H.X., Deng B., Gotoh T., Tidball J.G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 2009, 18:482-496.
25. Villalta S.A., Rinaldi C., Deng B., Liu G., Fedor B., Tidball J.G. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum. Mol. Genet. 2010, 20:790-805.
26. Nemoto H., Konno S., Sugimoto H., Nakazora H., Nomoto N., Murata M., Kitazono H., Fujioka T. Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice. Exp. Mol. Pathol. 2010, 90:264-270.
27. Tidball J.G., Villalta S.A. Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R1173-R1187.
28. Suzuki N., Aoki M., Hinuma Y., Takahashi T., Onodera Y., Ishigaki A., Kato M., Warita H., Tateyama M., Itoyama Y. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL). Neurosci. Res. 2005, 52:47-60.
29. Schuler W., Weiler I.J., Schuler A., Phillips R.A., Rosenberg N., Mak T.W., Kearney J.F., Perry R.P., Bosma M.J. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 1986, 46:963-972.
30. Benchaouir R., Meregalli M., Farini A., D'Antona G., Belicchi M., Goyenvalle A., Battistelli M., Bresolin N., Bottinelli R., Garcia L., Torrente Y. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 2007, 1:646-657.
31. Torrente Y., Belicchi M., Sampaolesi M., Pisati F., Meregalli M., D'Antona G., Tonlorenzi R., Porretti L., Gavina M., Mamchaoui K., Pellegrino M.A., Furling D., Mouly V., Butler-Browne G.S., Bottinelli R., Cossu G., Bresolin N. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 2004, 114:182-195.
32. Farini A., Meregalli M., Belicchi M., Battistelli M., Parolini D., D'Antona G., Gavina M., Ottoboni L., Constantin G., Bottinelli R., Torrente Y. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. J. Pathol. 2007, 213:229-238.
33. Araki R., Fujimori A., Hamatani K., Mita K., Saito T., Mori M., Fukumura R., Morimyo M., Muto M., Itoh M., Tatsumi K., Abe M. Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:2438-2443.
34. Blunt T., Gell D., Fox M., Taccioli G.E., Lehmann A.R., Jackson S.P., Jeggo P.A. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10285-10290.
35. Brunelli S., Sciorati C., D'Antona G., Innocenzi A., Covarello D., Galvez B.G., Perrotta C., Monopoli A., Sanvito F., Bottinelli R., Ongini E., Cossu G., Clementi E. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:264-269.
36. Bottinelli R., Canepari M., Pellegrino M.A., Reggiani C. Force-velocity properties of human skeletal muscle fibres: myosin heavy chain isoform and temperature dependence. J. Physiol. 1996, 495(Pt 2):573-586.
37. D'Antona G., Lanfranconi F., Pellegrino M.A., Brocca L., Adami R., Rossi R., Moro G., Miotti D., Canepari M., Bottinelli R. Skeletal muscle hypertrophy and structure and function of skeletal muscle fibres in male body builders. J. Physiol. 2006, 570:611-627.
38. D'Antona G., Pellegrino M.A., Adami R., Rossi R., Carlizzi C.N., Canepari M., Saltin B., Bottinelli R. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J. Physiol. 2003, 552:499-511.
39. Van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 1994, 174:83-93.
40. Heslop L., Morgan J.E., Partridge T.A. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 2000, 113(Pt 12):2299-2308.
41. Nguyen K., Bassez G., Krahn M., Bernard R., Laforet P., Labelle V., Urtizberea J.A., Figarella-Branger D., Romero N., Attarian S., Leturcq F., Pouget J., Levy N., Eymard B. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch. Neurol. 2007, 64:1176-1182.
42. Nguyen H.X., Tidball J.G. Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. J. Physiol. 2003, 547:125-132.
43. Schertzer J.D., Gehrig S.M., Ryall J.G., Lynch G.S. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice. Am. J. Pathol. 2007, 171:1180-1188.
44. Brickson S., Ji L.L., Schell K., Olabisi R., St Pierre B. Schneider, T.M. Best, M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury. J. Appl. Physiol. 2003, 95:969-976.
45. Chiu Y.H., Hornsey M.A., Klinge L., Jorgensen L.H., Laval S.H., Charlton R., Barresi R., Straub V., Lochmuller H., Bushby K. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy. Hum. Mol. Genet. 2009, 18:1976-1989.
46. Barton E.R., Wang B.J., Brisson B.K., Sweeney H.L. Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice. Muscle Nerve 2010, 42:22-29.
47. Qian Q., Jutila M.A., Van Rooijen N., Cutler J.E. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 1994, 152:5000-5008.